Table I.
Correlation between miR-222 or BBC3 and the characteristics of liver cancer patients.
| Factor | Cases (n) | miR-222 | P-value | BBC3 | P-value |
|---|---|---|---|---|---|
| Sex | |||||
| Male | 27 | 2.75±1.34 | 0.79 | 2.63±0.68 | 0.27 |
| Female | 4 | 2.95±1.12 | 2.67±0.47 | ||
| Age (years) | |||||
| <60 | 13 | 2.99±1.53 | 0.51 | 1.97±0.64 | 0.68 |
| ≥60 | 18 | 2.65±1.32 | 2.13±0.33 | ||
| Maximum tumor size (cm) | |||||
| ≥5 | 11 | 3.13±0.66 | 0.02 | 2.29±0.36 | 0.04 |
| <5 | 20 | 2.37±0.85 | 2.88±0.44 | ||
| Histological grade | |||||
| Well/moderate differentiation | 15 | 2.78±1.33 | 0.25 | 2.45±0.57 | 0.08 |
| Poor differentiation | 16 | 2.24±1.25 | 2.87±0.68 | ||
| Metastasis | |||||
| No | 28 | 2.49±0.63 | 0.04 | 2.99±0.49 | 0.01 |
| Yes | 3 | 3.27±0.34 | 2.11±0.42 |
Values are expressed as the mean ± standard error of the mean. BBC3, B-cell lymphoma-2 binding component 3; miR, microRNA.